-
A Marra
Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy.
-
S Morganti
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA; Department of Medicine, Harvard Medical School, Boston, USA; Gerstner Center for Cancer Diagnostics, Broad Institute of MIT and Harvard, Boston, USA.
-
F Pareja
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
-
G Campanella
Hasso Plattner Institute for Digital Health, Mount Sinai Medical School, New York, USA; Department of AI and Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
-
F Bibeau
Department of Pathology, University Hospital of Besançon, Besancon, France.
-
T Fuchs
Hasso Plattner Institute for Digital Health, Mount Sinai Medical School, New York, USA; Department of AI and Human Health, Icahn School of Medicine at Mount Sinai, New York, USA.
-
M Loda
Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, USA; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK; Department of Oncologic Pathology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA.
-
A Parwani
Department of Pathology, Wexner Medical Center, Ohio State University, Columbus, USA.
-
A Scarpa
Department of Diagnostics and Public Health, Section of Pathology, University and Hospital Trust of Verona, Verona, Italy; ARC-Net Research Center, University of Verona, Verona, Italy.
-
J S Reis-Filho
Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
-
G Curigliano
Division of Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
-
C Marchiò
Candiolo Cancer Institute, FPO IRCCS, Candiolo, Italy; Department of Medical Sciences, University of Turin, Turin, Italy.
-
J N Kather
Else Kroener Fresenius Center for Digital Health, Medical Faculty Carl Gustav Carus, Technical University Dresden, Dresden, Germany; Department of Medicine I, University Hospital and Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; Medical Oncology, National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Heidelberg, Germany. Electronic address: education@esmo.org.
